WCG Clinical Files to Withdraw IPO
WCG Clinical Files to Withdraw IPO
In August, the company said it planned to offer 45 million shares and expected the offering to price between $15 and $17 per share. By Stephen Nakrosis
作者：斯蒂芬·纳克西
WCG Clinical, Inc. on Wednesday filed with the Securities and Exchange Commission to withdraw its initial public offering.
WCG Clinic，Inc.周三向美国证券交易委员会(Securities And Exchange Commission)提交了撤回其首次公开募股(IPO)的申请。
The company said it no longer wishes to conduct the offering at this time.
该公司表示，目前不再希望进行此次发行。
In August, the company said it planned to offer 45 million shares and expected the offering to price between $15 and $17 per share.
今年8月，该公司表示，计划发行4500万股票，预计发行价在每股15美元至17美元之间。
WCG Clinical said it provides clinical trial solutions and added it is "focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance."
WCG Clinic表示，它提供临床试验解决方案，并补充说，它“专注于提供旨在显著提高临床研究质量和效率、刺激增长和促进遵从性的解决方案。”
The company said it had total revenue of $137.6 million for the three months ended March 31, 2021. In the three months ended March 31, 2020, the company said, it had total revenue of $103.4 million.
该公司表示，截至2021年3月31日的三个月总收入为1.376亿美元。该公司表示，在截至2020年3月31日的三个月里，总营收为1.034亿美元。
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
写信给斯蒂芬·纳克希尔斯，电子邮件：stehen.naksim@wsj.com
译文内容由第三方软件翻译。
